|
| Column (C) | Mobile phase | Flow rate (ml/min) | Wavelength (nm) | Matrices | Reference |
|
| Supelcosil ABZ + (5 μm;150 × 4.6 mm) | 20 mM PDPB pH 2:ACN (94 : 6, , ). | 1 | 263 | Human serum | [30] |
| Hypersil BDS C18 | Acetate buffer pH 4:ACN (97.2 : 2.8 ) | 1 | 254 | Human plasma | [31] |
| Hypersil BDS C18 | MeOH:25 mM SDPM pH 3 (87 : 13 ) | 1 | 270 | Plasma and vitreous fluid | [32] |
| RP-C18 | Acetate buffer pH 3.5 : MeOH/triethylamine (82 : 18 v/v) | 1 | 263 | Goat plasma and milk | [33] |
| RP Ultrasphere XL-ODS C (75 × 4.6 mm I.D.) | 20 mM AA pH 4 : 7% ACN | 1 | 254 | Human serum | [34] |
| Onyx Monolithic C18 (20 cm– 4.6 mm) coupled to Phenomenex C18 GC (5 cm 4.6 mm) | MeOH: 10 mM DPHP pH 7 (gradient) | 1 | 254 | Human plasma and dialysate | [35] |
| C18 with pre-C | NaOH buffer pH 3 : 1 M phosphoric acid: 0.01 Mn-octylamine pH 3.0 : ACN | 1.3 | 259 | Human urine | [36] |
| μBondapak C18 (30 cm × 3.9 mm × 10 μm) | ACN: acetate buffer (5 : 95 ) | 2 | 280 | Plasma and dialysate-ultrafiltrate from patients | [37] |
| SupelcosilTMLC-18 (25 cm × 4.6 mm × 5 μm), with a C18 GC | ACN: 0.075 M acetate buffer pH 5 (8 : 92, ) | 0.8 | 230 | Human plasma of burn patients | [38] |
| 100 × 4.6 mm i.d. Perkin Elmer phenyl C (5 µm) | ACN (including 0.015 M pentane sulfonic acid sodium pH 3.4 + glacial acetic acid and 4 with 45% KOH):water (5.5 : 94 ) | 1.5 | 280 | Aqueous solution | [39] |
| XTerra C18 (250 × 4.6 mm, 5 μm) supported by Phenomenex C18 GC (4 × 3.0 mm) | MeOH : 40 mM phosphate buffer pH 3.2 | 1 | 260 | Plasma and amniotic fluid | [40] |
| LiChrospher 100 RP C18 (250 mm × 4 mm, 5 lm particles) | MeOH: 10 mM phosphate buffer pH 7 (25 : 75 ) | 1 | 256 | Human serum, cerebrospinal fluid, and urine | [41] |
| C18 | Acetate buffer pH 5.1: ACN: MeOH (5 : 20 : 75 v/v) | 1 | 212 | Pure and pharmaceutical dosage forms | [42] |
| Phenomenex ODS (4.6 × 250 mm, 5µ) | ACN : AA pH 4.9 : (8 : 92) | 1.5 | 256 | Pharmaceutical formulations | [43] |
| Acclaim 120 C18 (250 × 4.6 mm, 5 μm particle size) | MeOH: sodium acetate buffer pH 6 (11 : 89 ) | 1.8 | 220 | Injections | [44] |
| Luna C18 (250 × 4.6 mm; 5 μm) | Ethanol : water (45 : 55 v) | 0.5 | 258 | Pharmaceutical dosage Form | [45] |
| C18 (250 × 25 mm) 25 μm | Water: ACN (90 : 10 v/v) | 1 | 212 | CP in injections | [46] |
| Princeton-100 C18 (4.6 mm i.d × 250 mm., 5 µn) | ACN: 25 mM PDPB pH 6.2 (6 : 9 4 ) | 1 | 210 | Bulk and pharmaceuticals | [47] |
| Hypersil Gold pentafluorophenyl (PFP) 6 (2.1 by 100 mm, 1.9 m) | (a) 10 mM phosphoric acid
(b) ACN | 0.5 | 260 | Human plasma | [48] |
| C18 | (ACN/0.1 M phosphoric acid/NaOH buffer pH 3): 0.01 M n-octylamine pH 3 (gradient) | 1 | 256 | Human urine | [49] |
|
